Colorectal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 40 years of age or older
- People who are able to make their own decisions and give informed consent
- People who are able to complete a colorectal cancer risk factor questionnaire and take part in yearly follow-up interviews after joining
- People who are able to share any cancer-related diagnosis information from other hospitals with the research team during the study
Who may not be able to join:
- People who have a history of colorectal cancer or any other type of cancer
- People who have previously had surgery to remove part of the colon or rectum
- People who are currently receiving any treatment related to cancer
- People who have had a major medical procedure such as a blood transfusion or organ/tissue transplant within the past 3 months
- People who have taken part in another interventional clinical trial within the past 3 months
- People who are currently pregnant or breastfeeding
- People who have an autoimmune disease, an inherited genetic condition, or a mental health condition or disability (confirm with trial site)
- People who may have difficulty following the study requirements or completing the full study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Rui Liu, Doctor, Singlera Genomics Inc.
Phone: 010-57830127
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Sensitivity and specificity of polygene methylation detection in colorectal cancer; Negative predictive value and positive predictive value of polygene methylation in colorectal cancer
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.